ArticleTheranostics2023

Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma.

Zhengjun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.